Literature DB >> 6200935

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

M Popovic, M G Sarngadharan, E Read, R C Gallo.   

Abstract

A cell system was developed for the reproducible detection of human T-lymphotropic retroviruses (HTLV family) from patients with the acquired immunodeficiency syndrome (AIDS) or with signs or symptoms that frequently precede AIDS (pre-AIDS). The cells are specific clones from a permissive human neoplastic T-cell line. Some of the clones permanently grow and continuously produce large amounts of virus after infection with cytopathic (HTLV-III) variants of these viruses. One cytopathic effect of HTLV-III in this system is the arrangement of multiple nuclei in a characteristic ring formation in giant cells of the infected T-cell population. These structures can be used as an indicator to detect HTLV-III in clinical specimens. This system opens the way to the routine detection of HTLV-III and related cytopathic variants of HTLV in patients with AIDS or pre-AIDS and in healthy carriers, and it provides large amounts of virus for detailed molecular and immunological analyses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200935     DOI: 10.1126/science.6200935

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  857 in total

1.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.

Authors:  Z Lai; I Han; G Zirzow; R O Brady; J Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Multiplex detection of four pathogenic retroviruses using molecular beacons.

Authors:  J A Vet; A R Majithia; S A Marras; S Tyagi; S Dube; B J Poiesz; F R Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  Scientific reasoning and due process.

Authors:  Louis M Guenin; Bernard D Davis
Journal:  Sci Eng Ethics       Date:  1996-01       Impact factor: 3.525

5.  Histidine-Rich Glycoprotein Inhibits HIV-1 Infection in a pH-Dependent Manner.

Authors:  Juan Sabatté; Jorge Geffner; Ezequiel Dantas; Fernando Erra Díaz; Pehuén Pereyra Gerber; Augusto Varese; Diana Alicia Jerusalinsky; Alberto L Epstein; Hernán J García Rivello; Ana Del Valle Jaén; Julieta B Pandolfi; Ana Ceballos; Matias Ostrowski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

6.  Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.

Authors:  L O Arthur; J W Bess; D J Waters; S W Pyle; J C Kelliher; P L Nara; K Krohn; W G Robey; A J Langlois; R C Gallo
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Myelography in patients with acquired immuno deficiency syndrome. Indications and results.

Authors:  B J Borgstein; P A Koster; P Portegies; F L Peeters
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

8.  9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo.

Authors:  L Naesens; J Balzarini; I Rosenberg; A Holý; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

9.  The monomeric and dimeric mannose-binding proteins from the Orchidaceae species Listera ovata and Epipactis helleborine: sequence homologies and differences in biological activities.

Authors:  E J Van Damme; J Balzarini; K Smeets; F Van Leuven; W J Peumans
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

10.  Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.

Authors:  B A Castro; C D Weiss; L D Wiviott; J A Levy
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.